Medication management and preventive healthcare for adults with intellectual disabilities
Not Applicable
- Conditions
- F70-F79Mental retardation
- Registration Number
- DRKS00014101
- Lead Sponsor
- Hochschule für angewandte Wissenschaften Hamburg, Fakultät Wirtschaft und Soziales, Department Pflege und Management
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 164
Inclusion Criteria
1. Existence of a complex medication therapy (at least 5 drugs, pro re nata medication included)
2. German-speaking
Exclusion Criteria
1. Uncertain legal guardianship
2. Life-threatening illness
3. Acute infection with isolation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Medication adherence via structured interview with Medication Adherence Scale (MARS-D) (Proxy) at T0 and T1 after 3 months
- Secondary Outcome Measures
Name Time Method 1. Medication adherence via structured interview with Medication Ahderence Scale (MARS-D) (self-report) at T0 and T1 after 3 months<br>2. Health-related quality of life via structured interview with EQ-5D-3L (Proxy) at T0 and T1 after 3 months<br>3. Health-related quality of life via structured interview with EQ-5D-3L (self-report) at T0 and T1 after 3 months<br>4. General health status via structured interview with WHO-DAS 2.0 (Proxy) at T0 and T1 after 3 months<br>5. Medication regime complexity via MRCI-D at T0 and T1 after 3 months<br>6. Quantity of the active ingredient of psycotropic medication via documentary analysis at T0 and T1 after 3 months<br>7. Utilisation of preventive health care as defined in German Social Act (SGB) § 25 SGB V resp. §55.1 SGB V for dental health care via documentary analysis at T1 after 3 months